Work

Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.

Year: 1996
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: J L Steegmann, J Odriozola, F Rodriguez-Salvanés, P Giraldo, J García-Laraña, M T Ferro, E Benítez, C Pérez-Pons, M Giralt, L Escribano, E Lavilla, A Miguel, C Areal, M Pérez-Encinas, A Abad, J Maldonado, I Massagué, J M Fernández-Rañada
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W2168062293
FWCI: 0.7
Cites: 117
Cited by: 102
Related to: 10